Robert I. Nicholson

Cardiff, WLS CF103NB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Co-Administration of Fish Oil With Signal Transduction Inhibitors Has Anti-Migration Effects in Breast Cancer Cell Lines, in vitro.

Co-Administration of Fish Oil With Signal Transduction Inhibitors Has Anti-Migration Effects in Breast Cancer Cell Lines, in vitro.

Journal: The open biochemistry journal

Published: June 11, 2018

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Journal: Breast cancer research : BCR

Published: June 06, 2018

Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.

Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 25, 2015

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.

Journal: Nature communications

Published: March 18, 2015

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.

Journal: Cancer research

Published: February 04, 2015

A good drug made better: the fulvestrant dose-response story.

A good drug made better: the fulvestrant dose-response story.

Journal: Clinical breast cancer

Published: March 28, 2014

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.

Journal: International journal of cancer

Published: December 09, 2013

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells.

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells.

Journal: British journal of cancer

Published: September 18, 2013

Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.

Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.

Journal: PloS one

Published: August 06, 2013

Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.

Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.

Journal: Endocrine-related cancer

Published: August 01, 2013

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.

Journal: Molecular cancer therapeutics

Published: July 18, 2013

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.

Journal: Breast cancer research : BCR

Published: June 21, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026